TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Bioxyne Limited ( (AU:BXN) ) has shared an update.
Bioxyne Limited has filed a legal claim against Mr. Ian Owles, a major shareholder, in the Supreme Court of New South Wales. The company alleges that Mr. Owles made misrepresentations leading to the issuance of shares to him, and seeks remedies including the declaration of the shares as void or unenforceable. Bioxyne assures stakeholders that this legal action does not affect its ongoing operations.
More about Bioxyne Limited
Bioxyne Limited operates in the biotechnology industry and is listed on the Australian Securities Exchange under the ticker ASX:BXN. The company is involved in the development and commercialization of health and wellness products, focusing on probiotics and immune health solutions.
Average Trading Volume: 4,979,076
Technical Sentiment Signal: Buy
Current Market Cap: A$117.3M
For an in-depth examination of BXN stock, go to TipRanks’ Overview page.